Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer

卵巢癌小鼠模型中的排卵、包涵囊肿和 p53 突变

基本信息

  • 批准号:
    7943114
  • 负责人:
  • 金额:
    $ 7.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-29 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ovarian cancer is the most lethal gynecological malignancy among western women. The etiology of ovarian cancer is unknown, but intervention that blocks ovulation reduces the risk for developing ovarian cancer. For example, pregnancy, breast-feeding, use of oral contraceptives, and early menopause all reduce the risk for developing ovarian cancers. Ovarian inclusions cysts are possible precursor lesions of ovarian cancer. Alternatively, ovarian cancers may arise in fallopian tubal epithelial cells. We have developed a Smad2 dominant negative (Smad2DN) mouse that develops epithelial-lined ovarian inclusions cysts that resemble the fallopian epithelium (endosalpingiosis). When these animals are chronically superovulated for six months, they develop significantly more ovarian inclusions cysts than their normal littermate counterparts that are ovulation suppressed, but these cysts never developed into cancer. We hypothesize that the transition of ovarian inclusion cysts to cancer is a two hit process. In at least three other models of ovarian cancer, the mutation of p53 is required for lesions to develop. We therefore propose to develop a Smad2DN/floxedp53 bitransgenic mouse to provide the first animal model to directly investigate the link between ovulation and the transition of ovarian inclusion cysts or tubal epithelial cells into cancers. Specific Aim 1 will investigate the presence of ovarian cancer at 6 and 12 months in Smad2DN mice with the floxed p53 allele deleted in the ovarian surface using cre-recombinase intrabursal injections. Specific Aim 2 will investigate ovarian cancer in Smad2DN/floxedp53 mice with the floxed p53 allele deleted in the tubal epithelium using cre-recombinase intratubal injections. Specific Aim 3 will then compare superovulated and ovulation suppressed Smad2DN/floxedp53 mice with p53 deleted in either the OSE or the tube to investigate increased formation of cancers in response to ovulation in animals that have both the Smad and p53 pathways inactivated. Development of this model will provide two pathways for further investigation critical in ovarian cancer, p53 and Smad signaling. The model will help explore if inactivation in the tube or the ovary contributes to serous cancers. Lastly, will be able to conduct future studies in this mouse model aimed at generating therapies that prevent ovarian cancer.
描述(由申请人提供): 卵巢癌是西方妇女中最致命的妇科恶性肿瘤。卵巢癌的病因尚不清楚,但阻断排卵的干预措施可降低患卵巢癌的风险。例如,怀孕、母乳喂养、口服避孕药的使用和绝经早期都可以降低患卵巢癌的风险。卵巢内含物囊肿可能是卵巢癌的先兆病变。或者,卵巢癌可能发生在输卵管上皮细胞中。我们已经开发了一种Smad 2显性阴性(Smad 2DN)小鼠,其产生类似于输卵管上皮的上皮内衬卵巢内含物囊肿(输卵管内膜炎)。当这些动物长期超数排卵6个月时,它们比排卵抑制的正常同窝动物产生更多的卵巢内含物囊肿,但这些囊肿从未发展成癌症。我们假设卵巢包涵体囊肿向癌的转变是一个两次打击的过程。在至少三种其他卵巢癌模型中,p53突变是病变发展所必需的。因此,我们建议开发一种Smad 2DN/p53双转基因小鼠,以提供第一个动物模型,直接研究排卵和卵巢包涵体囊肿或输卵管上皮细胞转化为癌症之间的联系。具体目标1将使用cre重组酶囊内注射研究卵巢表面缺失floxed p53等位基因的Smad 2DN小鼠在6个月和12个月时卵巢癌的存在。具体目标2将使用cre重组酶输卵管内注射研究输卵管上皮中缺失floxed p53等位基因的Smad 2DN/p53小鼠中的卵巢癌。然后,特定目标3将比较超排卵和排卵抑制的Smad 2DN/p53小鼠,其中在OSE或试管中缺失p53,以研究在具有Smad和p53途径失活的动物中响应于排卵的癌症形成增加。该模型的建立将为进一步研究卵巢癌中的两个关键信号通路p53和Smad信号通路提供依据。该模型将有助于探索输卵管或卵巢中的失活是否有助于浆液性癌。最后,将能够在这种小鼠模型中进行未来的研究,旨在产生预防卵巢癌的疗法。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.
  • DOI:
    10.5483/bmbrep.2011.44.7.435
  • 发表时间:
    2011-07
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    King SM;Burdette JE
  • 通讯作者:
    Burdette JE
Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth.
  • DOI:
    10.1097/cad.0b013e32834ac8fc
  • 发表时间:
    2011-11
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Hilliard TS;Gaisina IN;Muehlbauer AG;Gaisin AM;Gallier F;Burdette JE
  • 通讯作者:
    Burdette JE
Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas.
  • DOI:
    10.1371/journal.pone.0065067
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Quartuccio SM;Lantvit DD;Bosland MC;Burdette JE
  • 通讯作者:
    Burdette JE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joanna E Burdette其他文献

Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment
  • DOI:
    10.1186/scrt374
  • 发表时间:
    2013-12-01
  • 期刊:
  • 影响因子:
    7.300
  • 作者:
    Monica M Laronda;Joanna E Burdette;J Julie Kim;Teresa K Woodruff
  • 通讯作者:
    Teresa K Woodruff

Joanna E Burdette的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joanna E Burdette', 18)}}的其他基金

Development of quantitative mass spectrometry assays and imaging for cancer metastasis
开发癌症转移的定量质谱分析和成像
  • 批准号:
    10533035
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
IRACDA at University of Illinois at Chicago
伊利诺伊大学芝加哥分校 IRACDA
  • 批准号:
    10055916
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis
研究癌症转移代谢物的成像质谱方法
  • 批准号:
    10393491
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
IRACDA at University of Illinois at Chicago
伊利诺伊大学芝加哥分校 IRACDA
  • 批准号:
    10460287
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis
研究癌症转移代谢物的成像质谱方法
  • 批准号:
    10737811
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
IRACDA at University of Illinois at Chicago
伊利诺伊大学芝加哥分校 IRACDA
  • 批准号:
    10672429
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
Imaging mass spectrometry methodologies for studying the metabolites of cancer metastasis
研究癌症转移代谢物的成像质谱方法
  • 批准号:
    10622483
  • 财政年份:
    2020
  • 资助金额:
    $ 7.85万
  • 项目类别:
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
高级别浆液性卵巢癌中卵巢-输卵管轴的动态相互作用
  • 批准号:
    10190857
  • 财政年份:
    2019
  • 资助金额:
    $ 7.85万
  • 项目类别:
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
高级别浆液性卵巢癌中卵巢-输卵管轴的动态相互作用
  • 批准号:
    10667563
  • 财政年份:
    2019
  • 资助金额:
    $ 7.85万
  • 项目类别:
Microfluidic Models of Ovarian Cancer Preneoplastic Lesions
卵巢癌癌前病变的微流体模型
  • 批准号:
    10062680
  • 财政年份:
    2019
  • 资助金额:
    $ 7.85万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 7.85万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 7.85万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 7.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了